MX9205792A - Derivados novedosos de asa-androstan 178-substituidos - Google Patents

Derivados novedosos de asa-androstan 178-substituidos

Info

Publication number
MX9205792A
MX9205792A MX9205792A MX9205792A MX9205792A MX 9205792 A MX9205792 A MX 9205792A MX 9205792 A MX9205792 A MX 9205792A MX 9205792 A MX9205792 A MX 9205792A MX 9205792 A MX9205792 A MX 9205792A
Authority
MX
Mexico
Prior art keywords
carbon atoms
fen
formula
group
substituted
Prior art date
Application number
MX9205792A
Other languages
English (en)
Spanish (es)
Inventor
Michel Biollaz
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of MX9205792A publication Critical patent/MX9205792A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
MX9205792A 1991-10-09 1992-10-08 Derivados novedosos de asa-androstan 178-substituidos MX9205792A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH297891 1991-10-09

Publications (1)

Publication Number Publication Date
MX9205792A true MX9205792A (es) 1993-08-01

Family

ID=4245915

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9205792A MX9205792A (es) 1991-10-09 1992-10-08 Derivados novedosos de asa-androstan 178-substituidos

Country Status (19)

Country Link
US (2) US5304562A (enExample)
EP (1) EP0538192B1 (enExample)
JP (1) JPH05213989A (enExample)
KR (1) KR930007969A (enExample)
AT (1) ATE152121T1 (enExample)
AU (1) AU657579B2 (enExample)
CA (1) CA2080054A1 (enExample)
DE (1) DE59208383D1 (enExample)
DK (1) DK0538192T3 (enExample)
ES (1) ES2101073T3 (enExample)
FI (1) FI924529A7 (enExample)
GR (1) GR3024013T3 (enExample)
HU (1) HUT62600A (enExample)
IL (1) IL103361A (enExample)
MX (1) MX9205792A (enExample)
NO (1) NO923911L (enExample)
NZ (1) NZ244640A (enExample)
TW (1) TW263513B (enExample)
ZA (1) ZA927747B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5304562A (en) * 1991-10-09 1994-04-19 Ciba-Geigy Corporation 17β-substituted Aza-androstane derivatives
WO1993023039A1 (en) * 1992-05-20 1993-11-25 Merck & Co., Inc. Substituted 4-aza-5a-androstan-ones as 5a-reductase inhibitors
SK137994A3 (en) * 1992-05-20 1995-04-12 Merck & Co Inc 7-beta-substituted-4-aza-5-alpha-cholestan-ons their using for production of pharmaceutical agent and pharmaceutical agent containing them
GB9210880D0 (en) * 1992-05-21 1992-07-08 Smithkline Beecham Corp Compounds
GB9216284D0 (en) * 1992-07-31 1992-09-16 Erba Carlo Spa Fluorinated 17beta-substituted 4-aza-5alpha-androstane-3-one derivatives
HU212459B (en) * 1992-10-02 1996-06-28 Richter Gedeon Vegyeszet Process for producing new 17-beta-substituted 4-aza-androstane-derivatives and pharmaceutical compositions containing them
DE69329933T2 (de) * 1992-10-06 2001-07-19 Merck & Co., Inc. 17-beta-carboxanilid derivate von 4-aza-5-alpha-androstan-3-one als 5-alpha-reduktase-hemmende arzneimittel
TW369521B (en) * 1993-09-17 1999-09-11 Smithkline Beecham Corp Androstenone derivative
TW408127B (en) * 1993-09-17 2000-10-11 Glaxo Inc Androstenones
US5470976A (en) * 1994-09-07 1995-11-28 Merck & Co., Inc. Process for the stereoselective reduction of steroid enelactams
US5543417A (en) * 1994-10-21 1996-08-06 Merck & Co., Inc. Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents
US5595996A (en) * 1994-10-25 1997-01-21 Merck & Co., Inc. 7-substituted 4-aza cholanic acid derivatives and their use
US5656613A (en) * 1995-01-04 1997-08-12 Merck & Co., Inc. Treatment of hyperandrogenic conditions
USRE39056E1 (en) * 1995-09-15 2006-04-04 Merck & Co, Inc. 4-Azasteroids for treatment of hyperandrogenic conditions
EP0859761A4 (en) * 1995-09-15 2000-01-26 Merck & Co Inc 4-AZASTEROIDS FOR TREATING HYPERANDROGEN STATES
US5998427A (en) * 1998-05-14 1999-12-07 Glaxo Wellcome Inc. Androstenones
US6645974B2 (en) 2001-07-31 2003-11-11 Merck & Co., Inc. Androgen receptor modulators and methods for use thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4377584A (en) * 1978-04-13 1983-03-22 Merck & Co., Inc. 4-Aza-17β-substituted-5α-androstan-3-one-reductase inhibitors
US4760071A (en) * 1984-02-27 1988-07-26 Merck & Co., Inc. 17β-N-monosubstituted carbamoyl-4-aza-5α-androst-1-en-3-ones which are active as testosterone 5α-reductase inhibitors
US5049562A (en) * 1984-02-27 1991-09-17 Merck & Co., Inc. 17β-acyl-4-aza-5α-androst-1-ene-3-ones as 5α-reductase inhibitors
NZ211145A (en) * 1984-02-27 1988-10-28 Merck & Co Inc 4-aza-5-alpha-androst-1-en-3-ones and pharmaceutical compositions
GB8505862D0 (en) * 1985-03-07 1985-04-11 Erba Farmitalia Steroidic 5alpha-reductase inhibitors
US4845104A (en) * 1986-11-20 1989-07-04 Merck & Co., Inc. Oxidized analogs of 17β-N-monosubstituted-carbamoyl-4-aza-5-α-androstan-3-ones
DE3780778T2 (de) * 1986-11-20 1993-01-14 Merck & Co Inc Topisches arzneimittel enthaltend 17-beta-methoxy-carbonyl-4-methyl-4-aza-5-alpha-androst-1-en-3-one.
US4888336A (en) * 1987-01-28 1989-12-19 Smithkline Beckman Corporation Steroid 5-alpha-reductase inhibitors
DE3888378T2 (de) * 1987-04-03 1994-09-29 Merck & Co Inc Behandlung von Prostatacarcinoma mit 17-beta-n-monosubstituierten-Carbamoyl-4-aza-5-alpha-Androst-1-en-3-onen.
US5237061A (en) * 1988-10-31 1993-08-17 Merck & Co., Inc. Methods of synthesizing benign prostatic hypertropic agents and their intermediates
ES2121570T3 (es) * 1989-07-07 1998-12-01 Endorecherche Inc Derivados de androgenos para uso en la inhibicion de la actividad de los esteroides sexuales.
CA2023157A1 (en) * 1989-08-21 1991-02-22 Gary H. Rasmusson 17 beta-acyl-4-aza-5 alpha-androst-1-ene-3-ones as 5 alpha-reductase inhibitors
US5120847A (en) * 1990-08-27 1992-06-09 Merck & Co., Inc. Process for iodinating or brominating the α-methylenic carbon of a secondary amide
IE76452B1 (en) * 1990-10-29 1997-10-22 Sankyo Co Azasteroid compounds for the treatment of prostatic hypertrophy their preparation and use
US5304562A (en) * 1991-10-09 1994-04-19 Ciba-Geigy Corporation 17β-substituted Aza-androstane derivatives

Also Published As

Publication number Publication date
CA2080054A1 (en) 1993-04-10
AU2626192A (en) 1993-04-22
IL103361A (en) 1997-06-10
ATE152121T1 (de) 1997-05-15
ES2101073T3 (es) 1997-07-01
EP0538192B1 (de) 1997-04-23
TW263513B (enExample) 1995-11-21
AU657579B2 (en) 1995-03-16
ZA927747B (en) 1993-04-13
FI924529A0 (fi) 1992-10-07
EP0538192A1 (de) 1993-04-21
JPH05213989A (ja) 1993-08-24
HU9203189D0 (en) 1992-12-28
US5378710A (en) 1995-01-03
KR930007969A (ko) 1993-05-20
IL103361A0 (en) 1993-03-15
GR3024013T3 (en) 1997-10-31
NO923911D0 (no) 1992-10-08
NZ244640A (en) 1994-12-22
DE59208383D1 (de) 1997-05-28
FI924529A7 (fi) 1993-04-10
DK0538192T3 (da) 1997-05-20
US5304562A (en) 1994-04-19
NO923911L (no) 1993-04-13
HUT62600A (en) 1993-05-28

Similar Documents

Publication Publication Date Title
MX9205792A (es) Derivados novedosos de asa-androstan 178-substituidos
DZ799A1 (fr) Composés bicycliques substitués.
MX9300031A (es) Derivados de piperazina, procedimiento para su preparacion y composicion farmaucetica que los contiene.
PE2896A1 (es) Derivado de la eritromicina, su procedimiento de preparacion y su aplicacion como medicamento
ES8603455A1 (es) Un metodo para preparar derivados de piperazina
ES2111654T3 (es) Derivados de piperazina como antagonistas de 5-ht1a.
ES2101858T3 (es) Derivados de geneserina como inhibidores de colinesterasa.
ES547826A0 (es) Un procedimiento para preparar nuevos derivados de 6-(4-fenilo sustituido -3(2h) piradazinona.
FI861410A0 (fi) Foerfarande foer framstaellning av terapeutiskt aktiva aminopropanolderivat.
ATE109770T1 (de) Derivate der coffeinsäure und pharmazeutische zusammensetzungen, die sie enthalten.
ES2001875A6 (es) Procedimiento para preparar nuevos derivados de aminoacidos
ES478062A1 (es) Procedimiento de obtencion de derivados bencimidazolicos.
IT1196423B (it) Benzotiazolin-composti
ES8707502A1 (es) Procedimiento para la preparacion de -aminocarbonil-1-ben- cil-3,4-dihidro-isoquinoleinas
DK384485D0 (da) 1,6-naphthyridinderivater med kardilaterende virkning
ES8506577A1 (es) Procedimiento para preparar un derivado de ester de cefalosporina
MX9204138A (es) Compuestos ditiano, procedimiento para su obtencion y medicamentos que los contienen
ES2094132T3 (es) Uso de derivados de xantina contra la ulcera peptica.
FI822706L (fi) Foerfarande foer framstaellning av farmakologiskt aktiva heteroaryloxipropanolaminer
TW366283B (en) Compounds for treatment of arrhythmia
PE20020895A1 (es) DERIVADOS DE CALOPOROSIDOS COMO INHIBIDORES DE LAS CINASAS DEPENDIENTES DE CICLINA CDK´s
ES8306161A1 (es) Un procedimiento para la preparacion de nuevos derivados de nitrosourea.
AR019725A1 (es) Composicion farmaceutica de utilidad en la terapia y profilaxis de enfermedades cutaneas
NO944476L (no) Tetrahydro - og perhydro-isokinolinderivater og terapeutiske midler inneholdende dem
ES2183636T3 (es) 4'-sustituido-4', 5'-dihidropsoralenos y sus usos terapeuticos.